Trevi Therapeutics, Inc. (TRVI)
13.78
-0.39
(-2.75%)
USD |
NASDAQ |
Dec 11, 12:04
Trevi Therapeutics Market Cap: 1.767B for Dec. 11, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Merck & Co., Inc. | 245.30B |
| Arbutus Biopharma Corp. | 904.88M |
| NovaBay Pharmaceuticals, Inc. | 345.27M |
| Palatin Technologies, Inc. | 25.10M |
| Theriva Biologics, Inc. | 7.625M |
Market Cap Related Metrics
| Price to Book Value | 9.310 |
| Price | 13.78 |
| Earnings Yield | -2.69% |